Articles In Press                   Back to the articles list | Back to browse issues page

Ethics code: IR.MUMS.MEDICAL.REC.1401.230

XML Print


1- Department of Anesthesiology and Critical Care, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2- Department of Anesthesiology and Critical Care, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran , mashhadil@mums.ac.ir
3- Department of Biostatistics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran
4- Dentistry Student, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:   (20 Views)

Background and Objective: Sepsis is among the main global causes of morbidity and mortality. Acute acidemia is often observed during critical illness, which reduces the effectiveness of catecholamines. Sodium bicarbonate injection is a management choice for severe metabolic acidemia. Determining the probability of hemodynamic stability by restoring intravascular volumes along with the administration of sodium bicarbonate within the first three hours in severe sepsis and septic shock management.
Methods: 72 patients with severe sepsis or septic shock were randomly allocated into two groups. In the control group, initial targeted treatment with 30 cc/kg of isotonic crystalloid serum was done in the first 3 hours, and in the intervention group, sodium bicarbonate was added to the volume of serum similar to the first group in the amount of half of the calculated deficiency. All orders, such as obtaining blood samples for necessary data and monitoring at the beginning and end of the intervention, were the same for both groups.
Results: There was no meaningful difference among groups in demographic information, hemodynamic variables and arterial blood gas analysis variables before treatment, duration of hospitalization, and patient mortality; The recorded data of average arterial pressure, systolic and diastolic blood pressure, central venous pressure, PH, HCO3, BE and Lactate at the end of the treatment recorded, a significant difference was observed in the two groups.
Conclusion: Adding SB to Early Goal-Directed Therapy may offer clinical and hemodynamic benefits, but limited sample size reduces generalizability. Further large-scale researches are required to confirm safety and efficacy.

     
Type of Study: Clinical Trials | Subject: Clinical Medicine
Received: 2024/11/30 | Accepted: 2023/01/11

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb